- Home
- SMA vs KYMR Comparison
SMA vs KYMR Comparison
Compare SMA & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMA
- KYMR
- Stock Information
- Founded
- SMA 2013
- KYMR 2015
- Country
- SMA United States
- KYMR United States
- Employees
- SMA N/A
- KYMR N/A
- Industry
- SMA
- KYMR Medicinal Chemicals and Botanical Products
- Sector
- SMA
- KYMR Health Care
- Exchange
- SMA NYSE
- KYMR Nasdaq
- Market Cap
- SMA 2.0B
- KYMR 1.8B
- IPO Year
- SMA 2025
- KYMR 2020
- Fundamental
- Price
- SMA $36.49
- KYMR $45.87
- Analyst Decision
- SMA Strong Buy
- KYMR Strong Buy
- Analyst Count
- SMA 7
- KYMR 16
- Target Price
- SMA $39.43
- KYMR $59.38
- AVG Volume (30 Days)
- SMA 483.1K
- KYMR 1.1M
- Earning Date
- SMA 08-07-2025
- KYMR 08-06-2025
- Dividend Yield
- SMA 1.09%
- KYMR N/A
- EPS Growth
- SMA N/A
- KYMR N/A
- EPS
- SMA N/A
- KYMR N/A
- Revenue
- SMA $235,799,000.00
- KYMR $58,885,000.00
- Revenue This Year
- SMA $67.70
- KYMR $43.38
- Revenue Next Year
- SMA $9.53
- KYMR $10.97
- P/E Ratio
- SMA N/A
- KYMR N/A
- Revenue Growth
- SMA 5.34
- KYMR N/A
- 52 Week Low
- SMA $29.89
- KYMR $19.45
- 52 Week High
- SMA $37.74
- KYMR $53.27
- Technical
- Relative Strength Index (RSI)
- SMA N/A
- KYMR 67.58
- Support Level
- SMA N/A
- KYMR $45.80
- Resistance Level
- SMA N/A
- KYMR $47.51
- Average True Range (ATR)
- SMA 0.00
- KYMR 2.86
- MACD
- SMA 0.00
- KYMR -0.03
- Stochastic Oscillator
- SMA 0.00
- KYMR 67.19
About SMA SMARTSTOP SELF STORAGE REIT INC
Smartstop Self Storage REIT Inc operates as a real estate investment trust. The trust owns, acquires, and operates self-storage properties. It operates in two segments namely, self-storage operations which generates key revenue, and managed REIT platform business. The investment objective is to focus on investing in self-storage facilities and related self-storage real estate investments that are expected to support sustainable stockholder distributions over the long term.
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.